🇺🇸 FDA

Company profile · Sponsor

Aura

Aura Biosciences

AURA · NYSE biotech BOSTON, MA, USA
Pipeline
6
Drugs
0
Patents
8

Quick answer

Aura (AURA) is a biotech company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker AURA
Exchange NYSE
Company type biotech
Headquarters BOSTON, MA, USA
SEC CIK 0001501796

Pipeline (6)

Search pipeline →

  1. BELZUPACAP SAROTALOCAN, Placebo (Sham injection) to Belzupacap Sarotalocan solution for sham injection 0.0 mg/mL, BELZUPACAP SAROTALOCAN

    Aura

    Primary Indeterminate Lesions or Small Choroidal Melanoma

    phase 3 small molecule active

    1 trial

  2. Bel-sar

    Aura

    Choroidal Melanoma

    phase 3 small molecule active

    1 trial

  3. AU-011

    Aura

    Eye Cancer

    phase 2 small molecule active

    1 trial

  4. AU-011

    Aura

    Uveal Melanoma

    phase 2 small molecule completed

    1 trial

  5. Light-activated AU-011

    Aura

    Uveal Melanoma

    phase 2 small molecule completed

    1 trial

  6. AU-011

    Aura

    Non-muscle-invasive Bladder Cancer

    phase 1 small molecule active

    1 trial

Patents (8)

Search patents →

  1. US 11786503

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11166936

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10874633

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10806716

    Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

    Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10688172

    HPV particles and uses thereof

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10596275

    Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10300150

    Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

    Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10179168

    HPV particles and uses thereof

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Aura?

Aura (AURA) is a biotech company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Aura sponsor?

We track 6 ClinicalTrials.gov-linked programs for Aura, including BELZUPACAP SAROTALOCAN, Placebo (Sham injection) to Belzupacap Sarotalocan solution for sham injection 0.0 mg/mL, BELZUPACAP SAROTALOCAN and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Aura company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.